Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bacterial Signaling

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genetic Toolbox Expansion Enables Constitutively Fluorescent Lacticaseibacillus rhamnosus for Functional Microbiome Research.

Microbial biotechnology·2026

Same author

Genetically Encoded SpyTag Enables Modular AAV Retargeting via SpyCatcher-Fused Ligands for Targeted Gene Delivery.

ACS synthetic biology·2025

Same author

Self-assembling information-processing biomaterial circuits.

Nature chemical biology·2025

Same author

Encapsulation-enhanced switchable protein release from engineered probiotic lactobacilli.

Journal of controlled release : official journal of the Controlled Release Society·2025

Same author

Activation of NF-κB Signaling by Optogenetic Clustering of IKKα and β.

Advanced biology·2025

Same author

Developing an <i>In Vitro</i> Model of Endotoxemia to Assess the Immunomodulatory Effects of Anti-Inflammatory Peptide-Secreting Living Therapeutics.

ACS pharmacology & translational science·2025

Search research articles

Related Experiment Video

Updated: May 29, 2025

Isolation of Soil Microorganisms Using iChip Technology

Isolation of Soil Microorganisms Using iChip Technology

Published on: January 10, 2025

Engineered microbial living matter for diagnostics, prevention, and therapy.

Ali Khazem¹, Rosanne Schmachtenberg², Anke Weiand³

¹INM - Leibniz Institute for New Materials, Saarbrücken, Germany.

Current Opinion in Biotechnology

|February 7, 2025

Summary

Engineered microorganisms offer personalized, sustainable healthcare. This review explores their use as living diagnostics and therapeutics for various diseases, highlighting clinical trial successes and future potential.

More Related Videos

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Published on: March 9, 2017

Electrowetting-based Digital Microfluidics Platform for Automated Enzyme-linked Immunosorbent Assay

Electrowetting-based Digital Microfluidics Platform for Automated Enzyme-linked Immunosorbent Assay

Published on: February 23, 2020

Related Experiment Videos

Last Updated: May 29, 2025

Isolation of Soil Microorganisms Using iChip Technology

Isolation of Soil Microorganisms Using iChip Technology

Published on: January 10, 2025

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Using Synthetic Biology to Engineer Living Cells That Interface with Programmable Materials

Published on: March 9, 2017

Electrowetting-based Digital Microfluidics Platform for Automated Enzyme-linked Immunosorbent Assay

Electrowetting-based Digital Microfluidics Platform for Automated Enzyme-linked Immunosorbent Assay

Published on: February 23, 2020

Area of Science:

Biotechnology and Synthetic Biology
Microbial Engineering
Medical Microbiology

Background:

Engineered microorganisms represent a novel frontier in healthcare.
They offer potential for patient-tailored, sustainable, and cost-effective solutions.
Current research focuses on their diagnostic and therapeutic applications.

Purpose of the Study:

To review recent advances in engineered microorganisms for diagnostics and therapeutics.
To highlight applications in acute and chronic disease management.
To discuss encapsulation, clinical trial outcomes, and future trends.

Main Methods:

Review of recent scientific literature on engineered microorganisms.
Analysis of applications in diagnostics, therapeutics, and prevention.
Examination of encapsulation techniques and clinical trial data.

Main Results:

Engineered microorganisms show promise as living diagnostics and therapeutics.
Applications span various acute and chronic diseases.
Encapsulation strategies enhance stability and efficacy.
Positive outcomes observed in ongoing clinical trials.

Conclusions:

Engineered living therapeutics are a rapidly advancing field.
Significant potential exists for personalized and sustainable healthcare.
Further research and development are crucial to overcome challenges and realize future trends.